Hotline TAVI 1: extended analysis of the randomised trials

Spokesperson: O. De Backer
SHOW MORE

Summary

Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.

Presentations available when logged in:

  • Incidence, evolution, and impact of cardiac damage in asymptomatic severe aortic stenosis
  • One-year outcomes of contemporary TAVI valves – a randomised, non-inferiority LANDMARK trial
  • Three-year results of a randomised study comparing two balloon-expandable TAVI valves